Please login to the form below
cancer control
This page shows the latest cancer control news and features for those working in and with pharma, biotech and healthcare.
MHRA authorises Mirati Therapeutics’ Krazati for non-small cell lung cancer
In the UK, over 43, 000 people are diagnosed with lung cancer every year. ... with advanced solid tumours harbouring the KRAS G12C mutation, which causes cancer cells to grow out of control.
Latest news
-
AstraZeneca/Daiichi Sankyo’s Enhertu recommended by NICE for advanced breast cancer
people have before their cancer gets worse, and allowing them to live normal, healthy lives for longer.”. ... The main goals of therapy for advanced breast cancer are to control the disease and improve survival, and it is therefore critical to continue
-
The White House reveals its ‘Cancer Cabinet’ line-up as its Moonshot initiative progresses
The Moonshot initiative involves multiple federal agencies, including the National Cancer Institute, the US Food and Drug Administration, Centers for Disease Control and Prevention (CDC) and the National Institutes of Health, ... cancer prevention,
-
UICC launches global ATOM Coalition to increase access to essential cancer medicines
If left unmonitored, deaths from cancer in poorer countries could rise to four million by 2040. ... The Union for International Cancer Control (UICC), as part of an alliance involving multiple partners, has launched The Access to Oncology Medicines (ATOM)
-
Seagen’s Tukysa granted NICE recommendation for breast cancer patients
positive unresectable locally advanced or metastatic breast cancer after two, or more prior anti-HER2 treatments. ... therapies. This is absolutely wonderful news as the drug combination can help control the cancer for longer and extend lives, including
-
EIT Health raises awareness on World Cancer Day 2022
This year’s World Cancer Day raises awareness of global inequities affecting access to care. ... World Cancer Day is an international awareness day led by the Union for International Cancer Control (UICC) and this year – on 4 February – the focus
More from news
Approximately 2 fully matching, plus 31 partially matching documents found.
Latest Intelligence
-
The impact of prostate cancer on global health
in enhanced DNA damage and anti-tumour activity in non-HRRm prostate cancer models. ... NC: Historically in the treatment of mCRPC, hormonal therapy has been used to control prostate cancer growth, with chemotherapy also.
-
Avoiding data pitfalls in clinical research
In a recent pilot study with Roche Pharmaceutical for a rare cancer indication, Medidata’s Synthetic Control Arm (SCA) pulled actual data from past studies to create well-matched control arms. ... The pilot was successful enough to be accepted for
-
Digital disruption
Combining ‘drag and drop’ computer simulations they’re trying to predict the best way to kill cancer cells with drugs that control their function. ... Next, they draw in the basic signalling pathways that can go wrong in cancer cells.
-
Winning the war against cancer
At a regional cancer control meeting in Riga last month the Czech Republic, Slovenia and The Netherlands were held up as examples to learn from in areas such as centralised registries, ... work carried out by the likes of the OECD with its Health at a
-
It’s time for pharma companies to become household names
Pharma helps people survive heart attacks, beat cancer, manage depression and control diabetes, but until the companies behind these medicines become a visible part of people's lives, they're never
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments? ... Take immunotherapy for example. Cancer immunotherapy is a form of treatment that uses the body’s own immune system to prevent, control and
-
World Cancer Day and the role of people-centred care
Enabling patients to play an active role in decisions about their care and respecting their decisions can empower them to regain their sense of control throughout their cancer journey. ... Newsom T. How to cope with loss of control as a cancer patient.
-
Immunotherapy in oncology
This has led to major progress in disease control and prolonging the survival of cancer patients, but there are still major areas of unmet need. ... Three states of interaction exist in immunoediting;. Elimination, in which the immune response eradicates
-
Enough already. It’s time for pharma companies to become household names
Pharma helps people survive heart attacks, beat cancer, manage depression and control diabetes, but until the companies behind these medicines become a visible part of people’s lives, they’re never
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
